Polyamidoamine Dendrimers: Brain-Targeted Drug Delivery Systems in Glioma Therapy

被引：2
作者：
Yan, Xinyi [1 ]
Chen, Qi [2 ]
机构：
[1] Zhejiang Chinese Med Univ, Sch Pharmaceut Sci, Key Lab Neuropharmacol & Translat Med Zhejiang Pro, Hangzhou 310053, Peoples R China
[2] Fuzhou Univ, Interdisciplinary Inst Med Engn, Fuzhou 350108, Peoples R China
来源：
POLYMERS | 2024年 / 16卷 / 14期
基金：
中国国家自然科学基金;
关键词：
PAMAM dendrimers; brain-targeted; drug delivery system; glioma; CO-MODIFIED PAMAM; IN-VITRO; ANTICANCER DRUG; POLY(AMIDOAMINE) DENDRIMERS; NANOPARTICLES; NANOCARRIER; POLYMERS; BARRIER; CELLS; NANOMEDICINE;
D O I：
10.3390/polym16142022
中图分类号：
O63 [高分子化学（高聚物）];
学科分类号：
070305 ; 080501 ; 081704 ;
摘要：
Glioma is the most common primary intracranial tumor, which is formed by the malignant transformation of glial cells in the brain and spinal cord. It has the characteristics of high incidence, high recurrence rate, high mortality and low cure rate. The treatments for glioma include surgical removal, chemotherapy and radiotherapy. Due to the obstruction of the biological barrier of brain tissue, it is difficult to achieve the desired therapeutic effects. To address the limitations imposed by the brain's natural barriers and enhance the treatment efficacy, researchers have effectively used brain-targeted drug delivery systems (DDSs) in glioma therapy. Polyamidoamine (PAMAM) dendrimers, as branched macromolecular architectures, represent promising candidates for studies in glioma therapy. This review focuses on PAMAM-based DDSs in the treatment of glioma, highlighting their physicochemical characteristics, structural properties as well as an overview of the toxicity and safety profiles.
引用
收藏
页数：16
相关论文
共 117 条
[11]   Drug delivery across the blood-brain barrier using focused ultrasound [J].
Burgess, Alison ;
Hynynen, Kullervo .
EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (05) :711-721
[12]   Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges [J].
Chatterjee, Bappaditya ;
Gorain, Bapi ;
Mohananaidu, Keithanchali ;
Sengupta, Pinaki ;
Mandal, Uttam Kumar ;
Choudhury, Hira .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 565 :258-268
[13]   Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives [J].
Cheng, Yiyun ;
Zhao, Libo ;
Li, Yiwen ;
Xu, Tongwen .
CHEMICAL SOCIETY REVIEWS, 2011, 40 (05) :2673-2703
[14]   Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules [J].
Choudhary, Sonam ;
Gupta, Lokesh ;
Rani, Sarita ;
Dave, Kaushalkumar ;
Gupta, Umesh .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[15]   Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood-Brain Barrier [J].
Cogill, Sinnead Anne ;
Lee, Jae-Hyeok ;
Jeon, Min-Tae ;
Kim, Do-Geun ;
Chang, Yongmin .
CELLS, 2024, 13 (10)
[16]   Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro [J].
Colombo, Mariana ;
Figueiro, Fabricio ;
Dias, Amanda de Fraga ;
Teixeira, Helder Ferreira ;
Oliveira Battastini, Ana Maria ;
Koester, Leticia Scherer .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 543 (1-2) :214-223
[17]   Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration [J].
Dai, Hui ;
Navath, Raghavendra S. ;
Balakrishnan, Bindu ;
Guru, Bharath Raja ;
Mishra, Manoj K. ;
Romero, Roberto ;
Kannan, Rangaramanujam M. ;
Kannan, Sujatha .
NANOMEDICINE, 2010, 5 (09) :1317-1329
[18]   The Blood-Brain Barrier [J].
Daneman, Richard ;
Prat, Alexandre .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (01)
[19]   The blood-brain barrier in health and disease [J].
Daneman, Richard .
ANNALS OF NEUROLOGY, 2012, 72 (05) :648-672
[20]   New Advances in General Biomedical Applications of PAMAM Dendrimers [J].
de Araujo, Renan Vinicius ;
Santos, Soraya da Silva ;
Ferreira, Elizabeth Igne ;
Giarolla, Jeanine .
MOLECULES, 2018, 23 (11)
12345678910